Skip to content
by IQAC KIITKIIT Deemed to be University — Internal Quality Assurance Cell

Publication2022

Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study

The record

Type
Publication
Date
1 June 2022
Level
National
Journal
Journal of the Royal College of Physicians of Edinburgh
Volume
52
Issue
2
Pages
100-104
Published
1 June 2022
DOI
10.1177/14782715221103402
Scopus ID
85136172436
ISSN
14782715
Authors
6
Open access
No
Citations
23
International co-authorship
No
Co-author countries
IN

Classification

Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.

UN Sustainable Development Goals

  1. 3 Ensure healthy lives and promote well-being for all at all ages

    GoalPrimaryHigh confidenceJudged

    Clinical study demonstrates nintedanib provides significantly greater improvement in CT severity scores for COVID-19 pneumonia lung fibrosis compared to pirfenidone therapy.

    High confidence
    The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
    Judged
    Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

Viksit Bharat @2047

  1. vb-1.2 Health and well-being

    Sub-themePrimaryHigh confidenceJudged

    Pharmacological treatment research advancing management of post-COVID complications and respiratory health outcomes.

    Produced by
    claude-haiku-4-5-20251001, under kortex-publication-v1

Each label above carries the instrument and the version that produced it. How each classification is reached.

Evidence

Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.

No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.

Provenance

Which source system this record came from, how many source rows were resolved into it, and when each was last read.

Source rows resolved into this record
1

Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.

Citing this record

This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.

KIIT Deemed to be University. “Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study”. Kortex.

Explore the full record